Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Rating) have received an average rating of "Moderate Buy" from the seven analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating on the company. The average 1 year price objective among brokers that have covered the stock in the last year is $15.58.
Several research firms have recently weighed in on ATEC. HC Wainwright upped their price objective on Alphatec from $19.00 to $20.00 in a research report on Friday, May 6th. Needham & Company LLC reduced their price target on Alphatec from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Thursday, May 26th. Finally, Lake Street Capital reissued a "buy" rating and set a $9.00 price target on shares of Alphatec in a research report on Friday, July 15th.Alphatec Stock Down 0.4 %
ATEC stock opened at $8.18 on Friday. The company has a debt-to-equity ratio of 7.78, a current ratio of 2.62 and a quick ratio of 1.76. The stock has a market capitalization of $832.40 million, a P/E ratio of -5.05 and a beta of 1.62. The business has a 50-day moving average of $7.13 and a 200-day moving average of $9.32. Alphatec has a fifty-two week low of $5.73 and a fifty-two week high of $15.31.
Alphatec (NASDAQ:ATEC - Get Rating) last posted its quarterly earnings data on Thursday, May 5th. The medical technology company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.14). The firm had revenue of $70.93 million for the quarter, compared to analyst estimates of $67.72 million. Alphatec had a negative return on equity of 210.22% and a negative net margin of 55.97%. On average, sell-side analysts anticipate that Alphatec will post -1.4 earnings per share for the current fiscal year. Insider Buying and Selling at Alphatec
In other Alphatec news, CEO Patrick Miles sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, May 18th. The stock was sold at an average price of $8.34, for a total value of $834,000.00. Following the sale, the chief executive officer now owns 5,858,634 shares in the company, valued at $48,861,007.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Alphatec news, major shareholder Jennifer N. Pritzker acquired 4,000 shares of the company's stock in a transaction on Friday, May 13th. The shares were purchased at an average price of $7.96 per share, for a total transaction of $31,840.00. Following the completion of the purchase, the insider now directly owns 46,200 shares of the company's stock, valued at $367,752. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Patrick Miles sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, May 18th. The shares were sold at an average price of $8.34, for a total value of $834,000.00. Following the completion of the sale, the chief executive officer now owns 5,858,634 shares in the company, valued at approximately $48,861,007.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have acquired 79,700 shares of company stock worth $563,300 and have sold 300,000 shares worth $2,339,500. Corporate insiders own 33.93% of the company's stock. Hedge Funds Weigh In On Alphatec
A number of large investors have recently made changes to their positions in ATEC. Nisa Investment Advisors LLC bought a new position in shares of Alphatec during the second quarter worth approximately $27,000. Beacon Investment Advisory Services Inc. bought a new position in shares of Alphatec during the second quarter worth approximately $65,000. Commonwealth Equity Services LLC bought a new position in shares of Alphatec during the second quarter worth approximately $66,000. Quantbot Technologies LP bought a new position in shares of Alphatec during the first quarter worth approximately $66,000. Finally, SG Americas Securities LLC bought a new position in shares of Alphatec during the first quarter worth approximately $108,000. Institutional investors own 53.52% of the company's stock. Alphatec Company Profile (Get Rating)
Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement.Featured ArticlesGet a free copy of the StockNews.com research report on Alphatec (ATEC)MarketBeat: Week in Review 8/1 - 8/5How to Use High Beta Stocks to Maximize Your Investing ProfitsCronos Group Inc's Revenues Are Up, Is It Time to Buy?Why Apple Could Be At All-Time Highs By Year EndBeyond Meat Is Not Beyond Hope, And It's Cheap
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alphatec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphatec wasn't on the list.
While Alphatec currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
What investors can learn from studying the past, as well as offering some ideas about asset classes with future potential.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.